SE425485B - 5-oxaprostaglandiner till anvendning for utstotning av ett embryo eller fetus under en normal human graviditet - Google Patents
5-oxaprostaglandiner till anvendning for utstotning av ett embryo eller fetus under en normal human graviditetInfo
- Publication number
- SE425485B SE425485B SE7406533A SE7406533A SE425485B SE 425485 B SE425485 B SE 425485B SE 7406533 A SE7406533 A SE 7406533A SE 7406533 A SE7406533 A SE 7406533A SE 425485 B SE425485 B SE 425485B
- Authority
- SE
- Sweden
- Prior art keywords
- oxaprostaglandins
- embryo
- emission
- normal human
- human pregnancy
- Prior art date
Links
- 210000003754 fetus Anatomy 0.000 title 1
- 210000001161 mammalian embryo Anatomy 0.000 title 1
- 230000035935 pregnancy Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/361,991 US3931279A (en) | 1973-05-21 | 1973-05-21 | 5-Oxa prostaglandin F2.sub.α analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE425485B true SE425485B (sv) | 1982-10-04 |
Family
ID=23424252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7406533A SE425485B (sv) | 1973-05-21 | 1974-05-16 | 5-oxaprostaglandiner till anvendning for utstotning av ett embryo eller fetus under en normal human graviditet |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3931279A (da) |
| JP (1) | JPS5752326B2 (da) |
| AU (1) | AU476680B2 (da) |
| BE (1) | BE815355A (da) |
| CH (1) | CH610300A5 (da) |
| DE (1) | DE2423156A1 (da) |
| DK (1) | DK145083C (da) |
| GB (1) | GB1448414A (da) |
| NL (1) | NL7406556A (da) |
| PL (1) | PL97783B1 (da) |
| SE (1) | SE425485B (da) |
| SU (1) | SU620207A3 (da) |
| ZA (1) | ZA742574B (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4024179A (en) * | 1972-11-08 | 1977-05-17 | Pfizer Inc. | Substituted ω-pentanorprostaglandins |
| US4387241A (en) * | 1974-11-01 | 1983-06-07 | American Cyanamid Company | Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives |
| DE2524955C3 (de) * | 1975-06-05 | 1981-12-03 | Hoechst Ag, 6000 Frankfurt | Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung |
| US4054737A (en) * | 1976-08-20 | 1977-10-18 | The Upjohn Company | Thromboxane B analogs |
| US4107427A (en) * | 1976-08-20 | 1978-08-15 | The Upjohn Company | Process and intermediates for preparing Thromboxane B1 |
| US4052552A (en) * | 1976-08-20 | 1977-10-04 | The Upjohn Company | Thromboxane b analogs |
| US4228296A (en) * | 1979-01-24 | 1980-10-14 | American Cyanamid Company | Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives |
| WO1982002833A1 (en) * | 1981-02-17 | 1982-09-02 | Gail Sansone Bazzano | The use of retinoids and their derivatives to increase the rate of growth of human scalp hair and to increase the rate of growth of fur in certain fur-bearing animals |
| WO1983002558A1 (en) * | 1981-11-09 | 1983-08-04 | Gail Sansone Bazzano | The use of retinoids and minoxidil (2,4,-diamino-6-piperidino-pyrimidine-3-oxide) to increase the rate of growth of human scalp hair and to treat certain types of alopecias |
| IL143477A (en) * | 2001-05-31 | 2009-07-20 | Finetech Pharmaceutical Ltd | Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives |
| GB0112699D0 (en) * | 2001-05-24 | 2001-07-18 | Resolution Chemicals Ltd | Process for the preparation of prostglandins and analogues thereof |
| US7109371B2 (en) * | 2004-01-05 | 2006-09-19 | Johnson Matthey Public Limited Company | Prostaglandin synthesis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754114A (fr) * | 1969-07-29 | 1971-01-29 | Upjohn Co | Nouveaux composes de la classe des prostaglandines et leur procede de preparation |
-
1973
- 1973-05-21 US US05/361,991 patent/US3931279A/en not_active Expired - Lifetime
-
1974
- 1974-04-23 ZA ZA00742574A patent/ZA742574B/xx unknown
- 1974-04-30 AU AU68394/74A patent/AU476680B2/en not_active Expired
- 1974-05-01 GB GB1915174A patent/GB1448414A/en not_active Expired
- 1974-05-13 DE DE2423156A patent/DE2423156A1/de not_active Withdrawn
- 1974-05-13 CH CH651874A patent/CH610300A5/xx not_active IP Right Cessation
- 1974-05-16 SE SE7406533A patent/SE425485B/xx unknown
- 1974-05-16 NL NL7406556A patent/NL7406556A/xx not_active Application Discontinuation
- 1974-05-20 JP JP49055663A patent/JPS5752326B2/ja not_active Expired
- 1974-05-20 SU SU742025131A patent/SU620207A3/ru active
- 1974-05-20 DK DK275074A patent/DK145083C/da active
- 1974-05-21 PL PL1974171289A patent/PL97783B1/pl unknown
- 1974-05-21 BE BE144587A patent/BE815355A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK145083B (da) | 1982-08-23 |
| AU476680B2 (en) | 1976-09-30 |
| ZA742574B (en) | 1975-04-30 |
| PL97783B1 (pl) | 1978-03-30 |
| DK145083C (da) | 1983-01-24 |
| SU620207A3 (ru) | 1978-08-15 |
| AU6839474A (en) | 1975-10-30 |
| JPS5752326B2 (da) | 1982-11-06 |
| CH610300A5 (da) | 1979-04-12 |
| NL7406556A (da) | 1974-11-25 |
| JPS5018441A (da) | 1975-02-26 |
| BE815355A (fr) | 1974-11-21 |
| GB1448414A (en) | 1976-09-08 |
| DE2423156A1 (de) | 1974-12-12 |
| US3931279A (en) | 1976-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE425311B (sv) | 5-oxaprostaglandiner till anvendning for utstotning av ett embryo eller ett fetus under en normal human graviditet | |
| IT971111B (it) | Mezzo diagnostico | |
| RO68025A (ro) | Procedeu pentru obtinerea 3-metilmercaptopropionaldehidei | |
| IT1025605B (it) | Procedimento per la preparazione di esametil tetralina | |
| SE425485B (sv) | 5-oxaprostaglandiner till anvendning for utstotning av ett embryo eller fetus under en normal human graviditet | |
| IT1031981B (it) | Cabina autoportante per ascensori | |
| SE397677B (sv) | Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra | |
| SE401440B (sv) | Rontgenanleggning for diagnosendamal | |
| AT342006B (de) | Atemalkohol-prufgerat | |
| IT1007421B (it) | Procedimento per la preparazione di aldeidi | |
| IT983048B (it) | Catalizzatore per la preparazione di antrachinone | |
| SE396753B (sv) | Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien | |
| IT1050675B (it) | Procedimento per la produzione di antrachinone | |
| TR16847A (tr) | Mikrogranuelatlarin yapilmasina mahsus usul | |
| IT1047960B (it) | Procedimento per la colata di lingotti | |
| SE395897B (sv) | Forfarande for framstellning av 7beta-acylamido-3-metyl-cef-3-em-4-karbonsyror | |
| SE406062B (sv) | Luftkuddefarkost | |
| IT1013103B (it) | Procedimento per la idroformilazio ne di composti non saturi | |
| IT1050684B (it) | Procedimento per la produzione di antrachinone | |
| AR200370A1 (es) | Un procedimiento para preparar acidos 7beta-(d-5-amino-5-carboxivaleramido)-3-(carbamoiloximetil)7-metoxi-3-cefem-4-carboxilico | |
| FI54519B (fi) | Styranordning foer fallhejare eller liknande | |
| SE434153B (sv) | 4,5-didehydroprostaglandiner till anvendning som verkframkallande medel eller medel for utstotning av ett embryo eller fetus hos gravida eller drektiga hondeggdjur | |
| IT951706B (it) | Procedimento per la preparazione di solfoni | |
| IT1019917B (it) | Pneumatico particolarmente adatto per aerei | |
| IT939178B (it) | Procedimento per la preparazione di alogenuri glicidiltrialchilam monici |